Press Releases

Date	Title	PDF Version
Feb 12, 2009	Alexion Reports Fourth Quarter and Full Year 2008 Results
Jan 29, 2009	New England Journal of Medicine Publishes Case Reports on the Investigational Use of Soliris(R) (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Jan 29, 2009	Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
Jan 12, 2009	Alexion Pharmaceuticals To Report Fourth Quarter and Full Year 2008 Results on February 12, 2009
Jan 12, 2009	Soliris(R) Receives Orphan Drug Designation in Japan
Jan 05, 2009	Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
Jan 05, 2009	Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
Dec 09, 2008	Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
Dec 08, 2008	Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
Dec 07, 2008	First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

Search